Research

Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026

ATS 2026 highlighted epithelial cytokine pathways as a common link in severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and COPD.

Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use

New real-world evidence presented at ATS 2026 indicates that initiating triple therapy earlier in asthma management may improve patient outcomes.

AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data

AIRSUPRA® (albuterol/budesonide) demonstrated a reduction in asthma exacerbations, addressing the need for improved rescue therapy.

IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction

IL-33 acts as both a pro-inflammatory cytokine and a contributor to mucus hypersecretion in COPD, complicating therapeutic targeting.

AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints

Advancements in Alpha-1 Antitrypsin Deficiency (AATD) focus on restoring AAT levels and achieving clinically meaningful endpoints.

New Biologic Offers Option for Severe Eosinophilic Asthma

A new biologic agent presented at ATS 2026 provides an additional treatment option for patients with severe eosinophilic asthma.

IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension

An adaptive clinical study programme for IKT-001 in Pulmonary Arterial Hypertension (PAH) was presented at ATS 2026, detailing a novel approach to trial design.

Pediatric Pulmonary Research Gaps Highlighted for Global Health

A review of pediatric pulmonary research emphasizes significant disparities in global health and underserved populations, underscoring critical unmet needs.

AI Algorithms Enhance Pulmonary Disease Management at ATS 2026

Artificial intelligence applications in pulmonary medicine, presented at ATS 2026, demonstrate utility in diagnosis, prognosis, and treatment optimization.

Acute Respiratory Failure: Lifespan Phenotypes and Trajectories

Acute respiratory failure (ARF) presents distinct physiological phenotypes and trajectories across pediatric and adult populations, necessitating age-specific management.